Frontier Biotechnologies was invited by the Ministry of Commerce of the People’s Republic of China and Beijing Holley-Cotec Pharamceuticals Co. Ltd to deliver a training lecture titled “HIV Treatment Trends and Introduction of Albuvirtide” at the “Seminar for Officials of Developing Countries”, including African English-speaking countries, held on 25th June, 2022. The lecture presented by Ms. Sesy Wong, Medical Affairs Director of International Markets, addressed 29 officials from Uganda, Tanzania and Kenya. Majority of them were exposed for the first time to technical information and knowledge related to HIV, hence the topic was very well received and garnered positive feedback that Frontier was invited a second time to deliver the lecture to another group of 23 officials from Ethiopia, Zambia, Venezuela, Jamaica, Panama, Kenya and Sri Lanka on 13th July, 2022.
This was a fruitful collaboration on scientific education with the Ministry of Commerce and Beijing Holley-Cotec Pharma and it was an invaluable opportunity to broaden the awareness of Frontier outside of China, as a fully-integrated biopharmaceutical company with research, development, manufacturing and commercialization capabilities.